title: Persistent cytomegalovirus infection: association with profound immunodeficiency and treatment with interferon.
abstract: Cytomegalovirus (CMV) was repeatedly isolated from urine and saliva of a 20-month-old male child with recurrent episodes of pneumonia, high fever, rash, lymphadenopathy, oral ulceration, and neutropenia. Immunologic evaluation revealed decreased serum IgG and IgA, increased IgM, depressed T- and B-lymphocyte functions, and decreased natural killer (NK) activity for herpes simplex-type I virus-infected targets. NK activity was augmented following exposure of the patient's lymphocytes to interferon (IF) in vitro. The child was treated with interferon (four courses, dosage varying from 2 million U/day to 1 million U three times/week for periods of 10, 28, 80, and 67 days, respectively, interspersed over 9 months) and hyperimmune plasma infusions every 3 weeks. Toward the end of interferon therapy oral Levamisole was started and a feeding gastrostomy was inserted to provide nutritional support. Clinical recovery was associated with reversal of immunologic abnormalities except for the hypogammaglobulinemia. Aggressive antiviral therapy (e.g., with IF) followed by immunostimulation (e.g., with Levamisole) may prove effective in controlling certain viral infections in immunodeficiency disorders.
mesh_terms: D000361:Agammaglobulinemia / Q000150:complications / Q000276:immunology* / Q000628:therapy; D000914:Antibodies, Viral / Q000032:analysis / Q000096:biosynthesis; D003587:Cytomegalovirus / Q000276:immunology / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000150:complications / Q000276:immunology* / Q000628:therapy; D003602:Cytotoxicity, Immunologic; D006801:Humans; D017098:IgA Deficiency; D017099:IgG Deficiency; D007074:Immunoglobulin G / Q000008:administration & dosage; D007075:Immunoglobulin M / Q000032:analysis; D007223:Infant; D007370:Interferon Type I / Q000008:administration & dosage* / Q000502:physiology; D007694:Killer Cells, Natural / Q000276:immunology; D007978:Levamisole / Q000008:administration & dosage; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000145:classification / Q000276:immunology; D008297:Male; D009503:Neutropenia / Q000097:blood / Q000209:etiology
chemical_list: D000914:Antibodies, Viral; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007370:Interferon Type I; D007978:Levamisole